Nicolas Leupin
Chief Medical Officer, NovoCure Ltd.
Companies
- NovoCure LtdChief Medical Officer Jan 11, 2024 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- NovoCure Ltd NVCR102,979 shares2$1.5M at $14.88Mar 4, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 4, 2026Sold 1,100 shares at $13.31 of NovoCure Ltd2
- Feb 27, 2026Sold 1,029 shares at $13.66 of NovoCure Ltd3
- Mar 4, 2025Granted 54,975 shares at $18.19 of NovoCure Ltd4
- Feb 27, 2025Sold 161 shares at $20.55 of NovoCure Ltd5
- Feb 27, 2025Sold 161 shares at $20.55 of NovoCure Ltd6
- Feb 27, 2025Sold 830 shares at $19.92 of NovoCure Ltd5
- Feb 27, 2025Sold 830 shares at $19.92 of NovoCure Ltd6
- Feb 27, 2024Granted 51,124 shares at $16.30 of NovoCure Ltd7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARNovoCure Ltd, Chief Medical Officer
- 2
- 3SEC EDGARForm 4 filed Mar 3, 2026
- 4SEC EDGARForm 4 filed Mar 6, 2025
- 5SEC EDGARForm 4 filed Mar 3, 2025
- 6SEC EDGARForm 4 filed Mar 3, 2025
- 7SEC EDGARForm 4 filed Feb 29, 2024